Table 3.
Characterization of vaxEffect@UniMiB users for the age stratification.a
| Age (years) | Medical history (N=2733), n (%) | Dose 1 | Dose 2 | Dose 3 | |||||
|
|
|
Admin.b (N=2360), n (%) | ADRc (N=2226), n (%) | Admin. (N=1779), n (%) | ADR (N=1610), n (%) | Admin. (N=179), n (%) | ADR (N=169), n (%) | ||
| <30 | 1301 (47.6) | 1024 (43.4) | 962 (43.2) | 955 (53.7) | 861 (53.5) | 64 (35.8) | 59 (34.9) | ||
| 30-55 | 1109 (40.6) | 1043 (44.2) | 983 (44.2) | 634 (35.6) | 575 (35.7) | 80 (44.7) | 76 (45.0) | ||
| >55 | 323 (11.8) | 293 (12.4) | 281 (12.6) | 190 (10.7) | 174 (10.8) | 35 (19.5) | 34 (20.1) | ||
aEach cell reports the absolute and the relative frequency computed for the sample size N reported in the column headings.
bAdmin.: individuals who submitted their vaccination data.
cADR: adverse drug reaction (individuals who registered their ADRs 7 days postvaccination).